https://www.hcvguidelines.org/reference/significant-reductions-in-drinking-following-brief-alcohol-treatment-provided-in-a-hepatitis-c-clinic/ 2025-08-26T00:31:39-04:00 https://www.hcvguidelines.org/reference/awareness-of-infection-knowledge-of-hepatitis-c-and-medical-follow-up-among-individuals-testing-positive-for-hepatitis-c-national-health-and-nutrition-examination-survey-2001-2008/ 2025-08-26T00:31:39-04:00 https://www.hcvguidelines.org/reference/chronic-hepatitis-c-virus-infection-in-the-united-states-national-health-and-nutrition-examination-survey-2003-to-2010/ 2025-08-26T00:31:39-04:00 https://www.hcvguidelines.org/reference/independent-and-combined-action-of-hepatitis-c-virus-infection-and-alcohol-consumption-on-the-risk-of-symptomatic-liver-cirrhosis/ 2025-08-26T00:31:39-04:00 https://www.hcvguidelines.org/reference/treatment-outcomes-with-pegylated-interferon-and-ribavirin-for-male-prisoners-with-chronic-hepatitis-c/ 2025-08-26T00:31:39-04:00 https://www.hcvguidelines.org/reference/national-surveillance-of-dialysis-associated-diseases-in-the-united-states-2002/ 2025-08-26T00:31:39-04:00 https://www.hcvguidelines.org/reference/safety-and-efficacy-of-ombitasvir-450-r-and-dasabuvir-and-ribavirin-in-hcv-hiv-1-co-infected-patients-receiving-atazanavir-or-raltegravir-art-regimens/ 2025-08-26T00:31:38-04:00 https://www.hcvguidelines.org/reference/patterns-and-predictors-of-treatment-initiation-and-completion-in-patients-with-chronic-hepatitis-c-virus-infection/ 2025-08-26T00:31:32-04:00 https://www.hcvguidelines.org/reference/hepatitis-b-virus-hepatitis-c-virus-coinfection-epidemiology-clinical-features-viral-interactions-and-treatment/ 2025-08-26T00:31:32-04:00 https://www.hcvguidelines.org/reference/blood-tests-to-diagnose-fibrosis-or-cirrhosis-in-patients-with-chronic-hepatitis-c-virus-infection-a-systematic-review/ 2025-08-26T00:31:32-04:00 https://www.hcvguidelines.org/reference/noninvasive-methods-to-assess-liver-disease-in-patients-with-hepatitis-b-or-c/ 2025-08-26T00:31:32-04:00 https://www.hcvguidelines.org/reference/a-comparison-of-treatment-eligibility-for-hepatitis-c-virus-in-hcv-monoinfected-versus-hcv-hiv-coinfected-persons-in-electronically-retrieved-cohort-of-hcv-infected-veterans/ 2025-08-26T00:31:32-04:00 https://www.hcvguidelines.org/reference/meta-analysis-of-observational-studies-hepatitis-c-and-survival-after-renal-transplant/ 2025-08-26T00:31:32-04:00 https://www.hcvguidelines.org/reference/a-sustained-virologic-response-reduces-risk-of-all-cause-mortality-in-patients-with-hepatitis-c/ 2025-08-26T00:31:31-04:00 https://www.hcvguidelines.org/reference/acute-hepatitis-c-virus-infection-a-chronic-problem/ 2025-08-26T00:31:31-04:00 https://www.hcvguidelines.org/reference/progression-of-liver-fibrosis-in-post-transplant-hepatitis-c-mechanisms-assessment-and-treatment/ 2025-08-26T00:31:31-04:00 https://www.hcvguidelines.org/reference/acute-hepatitis-c-in-patients-with-hiv/ 2025-08-26T00:31:31-04:00 https://www.hcvguidelines.org/reference/clinical-benefits-of-antiviral-therapy-in-patients-with-recurrent-hepatitis-c-following-liver-transplantation/ 2025-08-26T00:31:31-04:00 https://www.hcvguidelines.org/reference/sustained-drug-use-changes-after-hepatitis-c-screening-and-counseling-among-recently-infected-persons-who-inject-drugs-a-longitudinal-study/ 2025-08-26T00:31:31-04:00 https://www.hcvguidelines.org/reference/sampling-variability-of-liver-fibrosis-in-chronic-hepatitis-c/ 2025-08-26T00:31:30-04:00 https://www.hcvguidelines.org/reference/barriers-to-the-treatment-of-hepatitis-c-patient-provider-and-system-factors/ 2025-08-26T00:31:25-04:00 https://www.hcvguidelines.org/reference/prevalence-of-type-2-diabetes-mellitus-among-persons-with-hepatitis-c-virus-infection-in-the-united-states/ 2025-08-26T00:31:25-04:00 https://www.hcvguidelines.org/reference/eradication-of-hepatitis-c-virus-infection-and-the-development-of-hepatocellular-carcinoma-a-meta-analysis-of-observational-studies/ 2025-08-26T00:31:25-04:00 https://www.hcvguidelines.org/reference/contribution-of-obesity-to-hepatitis-c-related-fibrosis-progression/ 2025-08-26T00:31:25-04:00 https://www.hcvguidelines.org/reference/use-and-interpretation-of-virological-tests-for-hepatitis-c/ 2025-08-26T00:31:25-04:00 https://www.hcvguidelines.org/reference/distinguishing-acute-from-chronic-hepatitis-c-virus-hcv-infection-based-on-antibody-reactivities-to-specific-hcv-structural-and-nonstructural-proteins/ 2025-08-26T00:31:25-04:00 https://www.hcvguidelines.org/reference/causes-and-predictive-factors-of-mortality-in-a-cohort-of-patients-with-hepatitis-c-virus-related-cryoglobulinemic-vasculitis-treated-with-antiviral-therapy/ 2025-08-26T00:31:24-04:00 https://www.hcvguidelines.org/reference/relationship-of-liver-disease-stage-and-antiviral-therapy-with-liver-related-events-and-death-in-adults-coinfected-with-hiv-hcv/ 2025-08-26T00:31:24-04:00 https://www.hcvguidelines.org/reference/a-meta-analysis-of-randomized-trials-for-the-treatment-of-nonalcoholic-fatty-liver-disease/ 2025-08-26T00:31:24-04:00 https://www.hcvguidelines.org/reference/a-global-view-of-hepatitis-c-physician-knowledge-opinions-and-perceived-barriers-to-care/ 2025-08-26T00:31:24-04:00 https://www.hcvguidelines.org/reference/improving-access-to-hepatitis-c-care-for-urban-underserved-patients-using-a-primary-care-based-hepatitis-c-clinic/ 2025-08-26T00:31:24-04:00 https://www.hcvguidelines.org/reference/regression-of-splenic-lymphoma-after-treatment-of-hepatitis-c-virus-infection/ 2025-08-26T00:31:24-04:00 https://www.hcvguidelines.org/reference/preventive-medication-use-among-persons-with-limited-life-expectancy/ 2025-08-26T00:31:23-04:00 https://www.hcvguidelines.org/reference/the-high-comorbidity-burden-of-the-hepatitis-c-virus-infected-population-in-the-united-states/ 2025-08-26T00:31:17-04:00 https://www.hcvguidelines.org/reference/hepatitis-c-virus-associated-glomerulonephritis-effect-of-alpha-interferon-therapy/ 2025-08-26T00:31:16-04:00 https://www.hcvguidelines.org/reference/acute-hepatitis-c-a-systematic-review/ 2025-08-26T00:31:16-04:00 https://www.hcvguidelines.org/reference/cost-effective-screening-for-acute-hepatitis-c-virus-infection-in-hiv-infected-men-who-have-sex-with-men/ 2025-08-26T00:31:16-04:00 https://www.hcvguidelines.org/reference/indications-for-testing-among-reported-cases-of-hcv-infection-from-enhanced-hepatitis-surveillance-sites-in-the-united-states-2004-2010/ 2025-08-26T00:31:16-04:00 https://www.hcvguidelines.org/reference/a-simple-strategy-to-identify-acute-hepatitis-c-virus-infection-among-newly-incarcerated-injection-drug-users/ 2025-08-26T00:31:15-04:00 https://www.hcvguidelines.org/reference/fibrosis-in-chronic-hepatitis-c-correlates-significantly-with-body-mass-index-and-steatosis/ 2025-08-26T00:31:15-04:00 https://www.hcvguidelines.org/reference/reasons-why-patients-infected-with-chronic-hepatitis-c-virus-choose-to-defer-treatment-do-they-alter-their-decision-with-time/ 2025-08-26T00:31:15-04:00 https://www.hcvguidelines.org/reference/the-liver-biopsy-in-chronic-hepatitis-c-a-view-from-the-other-side-of-the-microscope/ 2025-08-26T00:31:14-04:00 https://www.hcvguidelines.org/reference/hepatitis-c-a-multifaceted-disease-review-of-extrahepatic-manifestations/ 2025-08-26T00:31:08-04:00 https://www.hcvguidelines.org/reference/shea-guideline-for-management-of-healthcare-workers-who-are-infected-with-hepatitis-b-virus-hepatitis-c-virus-and-or-human-immunodeficiency-virus/ 2025-08-26T00:31:08-04:00 https://www.hcvguidelines.org/reference/clinical-virologic-histologic-and-biochemical-outcomes-after-successful-hcv-therapy-a-5-year-follow-up-of-150-patients/ 2025-08-26T00:31:07-04:00 https://www.hcvguidelines.org/reference/eradication-of-hepatitis-c-infection-the-importance-of-targeting-people-who-inject-drugs/ 2025-08-26T00:31:07-04:00 https://www.hcvguidelines.org/reference/hepatitis-c-virus-reinfection-following-treatment-among-people-who-use-drugs/ 2025-08-26T00:31:07-04:00 https://www.hcvguidelines.org/reference/risk-factors-barriers-and-facilitators-for-linkage-to-antiretroviral-therapy-care-a-systematic-review/ 2025-08-26T00:31:07-04:00 https://www.hcvguidelines.org/reference/hepatitis-c-in-the-united-states/ 2025-08-26T00:31:07-04:00 https://www.hcvguidelines.org/reference/sofosbuvir-compassionate-use-program-for-patients-with-severe-recurrent-hepatitis-c-after-liver-transplantation/ 2025-08-26T00:31:07-04:00 https://www.hcvguidelines.org/reference/treatment-of-hcv-infection-in-patients-with-advanced-cirrhosis/ 2025-08-26T00:31:07-04:00 https://www.hcvguidelines.org/reference/reactivation-of-hepatitis-b-virus-during-interferon-free-therapy-with-daclatasvir-and-asunaprevir-in-patient-with-hepatitis-b-virus-hepatitis-c-virus-co-infection/ 2025-08-26T00:31:06-04:00 https://www.hcvguidelines.org/reference/the-prevalence-and-the-risk-behaviours-associated-with-the-transmission-of-hepatitis-c-virus-in-australian-correctional-facilities/ 2025-08-26T00:31:06-04:00 https://www.hcvguidelines.org/reference/nucleoside-analogues-and-mitochondrial-toxicity/ 2025-08-26T00:31:06-04:00 https://www.hcvguidelines.org/reference/impact-of-hepatitis-c-on-survival-in-dialysis-patients-a-link-with-cardiovascular-mortality/ 2025-08-26T00:31:06-04:00 https://www.hcvguidelines.org/reference/systematic-review-regression-of-lymphoproliferative-disorders-after-treatment-for-hepatitis-c-infection/ 2025-08-26T00:31:06-04:00 https://www.hcvguidelines.org/reference/validation-of-a-strategy-for-hcv-antibody-testing-with-two-enzyme-immunoassays-in-a-routine-clinical-laboratory/ 2025-08-26T00:30:58-04:00 https://www.hcvguidelines.org/reference/persistence-of-viremia-and-the-importance-of-long-term-follow-up-after-acute-hepatitis-c-infection/ 2025-08-26T00:30:58-04:00 https://www.hcvguidelines.org/reference/impact-of-alcohol-on-the-histological-and-clinical-progression-of-hepatitis-c-infection/ 2025-08-26T00:30:58-04:00 https://www.hcvguidelines.org/reference/hepatitis-c-infection-and-risk-of-diabetes-a-systematic-review-and-meta-analysis/ 2025-08-26T00:30:58-04:00 https://www.hcvguidelines.org/reference/incidence-and-transmission-patterns-of-acute-hepatitis-c-in-the-united-states-1982-2006/ 2025-08-26T00:30:58-04:00 https://www.hcvguidelines.org/reference/fatigue-before-during-and-after-antiviral-therapy-of-chronic-hepatitis-c-results-from-the-virahep-c-study/ 2025-08-26T00:30:57-04:00 https://www.hcvguidelines.org/reference/antiviral-therapy-of-hepatitis-c-in-2014-do-we-need-resistance-testing/ 2025-08-26T00:30:57-04:00 https://www.hcvguidelines.org/reference/alcohol-and-hepatitis-c/ 2025-08-26T00:30:57-04:00 https://www.hcvguidelines.org/reference/noninvasive-measures-of-liver-fibrosis/ 2025-08-26T00:30:57-04:00 https://www.hcvguidelines.org/reference/sampling-error-and-intraobserver-variation-in-liver-biopsy-in-patients-with-chronic-hcv-infection/ 2025-08-26T00:30:57-04:00 https://www.hcvguidelines.org/reference/comparison-of-daclatasvir-resistance-barriers-on-ns5a-from-hepatitis-c-virus-genotypes-1-to-6-implications-for-cross-genotype-activity/ 2025-08-26T00:30:57-04:00 https://www.hcvguidelines.org/reference/liver-biopsy-in-the-evaluation-of-patients-with-chronic-hepatitis-c-who-have-repeatedly-normal-or-near-normal-serum-alanine-aminotransferase-levels/ 2025-08-26T00:30:47-04:00 https://www.hcvguidelines.org/reference/acute-hepatitis-c-transmitted-by-needlestick-accident-despite-short-duration-interferon-treatment/ 2025-08-26T00:30:47-04:00 https://www.hcvguidelines.org/reference/increased-early-acute-cellular-rejection-events-in-hepatitis-c-positive-heart-transplantation/ 2025-08-26T00:30:46-04:00 https://www.hcvguidelines.org/reference/liver-transplantation-using-hepatitis-c-virus-viremic-donors-into-hepatitis-c-virus-aviremic-recipients-as-standard-of-care/ 2025-08-26T00:30:46-04:00 https://www.hcvguidelines.org/reference/patterns-of-drug-and-alcohol-use-and-injection-equipment-sharing-among-people-with-recent-injection-drug-use-or-receiving-opioid-agonist-treatment-during-and-following-hepatitis-c-virus-treatment-with/ 2025-08-26T00:30:46-04:00 https://www.hcvguidelines.org/reference/illicit-drug-use-in-sexual-settings-chemsex-and-hiv-sti-transmission-risk-behaviour-among-gay-men-in-south-london-findings-from-a-qualitative-study/ 2025-08-26T00:30:46-04:00 https://www.hcvguidelines.org/reference/four-week-direct-acting-antiviral-prophylaxis-for-kidney-transplantation-from-hepatitis-c-viremic-donors-to-hepatitis-c-negative-recipients-an-open-label-nonrandomized-study/ 2025-08-26T00:30:46-04:00 https://www.hcvguidelines.org/reference/the-treatment-cascade-for-chronic-hepatitis-c-virus-infection-in-the-united-states-a-systematic-review-and-meta-analysis/ 2025-08-26T00:30:46-04:00 https://www.hcvguidelines.org/reference/enhancing-assessment-and-treatment-of-hepatitis-c-in-the-custodial-setting/ 2025-08-26T00:30:46-04:00 https://www.hcvguidelines.org/reference/pharmacokinetics-safety-and-efficacy-of-glecaprevir-pibrentasvir-in-children-with-chronic-hepatitis-c-virus-part-2-of-the-dora-study/ 2025-08-26T00:30:45-04:00 https://www.hcvguidelines.org/reference/hcv-positive-allograft-use-in-heart-transplantation-is-associated-with-increased-access-to-overdose-donors-and-reduced-waitlist-mortality-without-compromising-outcomes/ 2025-08-26T00:30:39-04:00 https://www.hcvguidelines.org/reference/excerpt-from-phs-guideline-for-reducing-hiv-hbv-and-hcv-transmission-through-organ-transplantation/ 2025-08-26T00:30:39-04:00 https://www.hcvguidelines.org/reference/estimating-the-year-each-state-in-the-united-states-will-achieve-the-world-health-organizations-elimination-targets-for-hepatitis-c/ 2025-08-26T00:30:39-04:00 https://www.hcvguidelines.org/reference/protease-inhibitor-based-direct-acting-antivirals-are-associated-with-increased-risk-of-aminotransferase-elevations-but-not-hepatic-dysfunction-or-decompensation/ 2025-08-26T00:30:38-04:00 https://www.hcvguidelines.org/reference/nucleic-acid-testing-for-diagnosis-of-perinatally-acquired-hepatitis-c-virus-infection-in-early-infancy/ 2025-08-26T00:30:38-04:00 https://www.hcvguidelines.org/reference/sofosbuvir-and-risk-of-estimated-glomerular-filtration-rate-decline-or-end-stage-renal-disease-in-patients-with-renal-impairment/ 2025-08-26T00:30:32-04:00 https://www.hcvguidelines.org/reference/hepatitis-c-prevalence-in-incarcerated-settings-between-2013-2021-a-systematic-review-and-meta-analysis/ 2025-08-26T00:30:31-04:00 https://www.hcvguidelines.org/reference/global-prevalence-of-injecting-drug-use-and-sociodemographic-characteristics-and-prevalence-of-hiv-hbv-and-hcv-in-people-who-inject-drugs-a-multistage-systematic-review/ 2025-08-26T00:30:30-04:00 https://www.hcvguidelines.org/reference/hepatitis-c-virus-risk-among-young-people-who-inject-drugs/ 2025-08-26T00:30:30-04:00